Home › Funds › SOFTBANK GROUP CORP. › ABCL

SOFTBANK GROUP CORP. position in ABCL

ABCELLERA BIOLOGICS INC · Health Care

SOFTBANK GROUP CORP. reported holding 172,581 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.02% of its reported portfolio and ranking #25 among its reported holdings. SOFTBANK GROUP CORP. has disclosed ABCL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)172.58K sh
Reported value held$2.52M
Portfolio Weight0.02%
First reportedQ4 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SOFTBANK GROUP CORP.'s ABCL position evolved

SOFTBANK GROUP CORP. first disclosed a stake in ABCL in Q4 2025 at 345,161 shares (US$1.2M). The position peaked in Q2 2026 at 345,161 shares, worth US$2.7M. Across 4 filings, SOFTBANK GROUP CORP. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 172,581 shares valued at US$2.5M — a reduction of -172,580 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 345.16K $1.18M New
Q1 2026 345.16K $1.20M Hold
Q2 2026 345.16K $2.71M Hold
Q3 2026 172.58K $2.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABCL and 13F data

ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 46 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$70.4M), ADAR1 Capital Management, LLC (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABCL

All ABCL fund holders →

FAQ

How long has SOFTBANK GROUP CORP. held ABCL?

SOFTBANK GROUP CORP. has disclosed ABCL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is SOFTBANK GROUP CORP.'s current position in ABCL?

As of Q3 2026, SOFTBANK GROUP CORP. holds 172.58K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $2.52M, representing 0.02% of its reported portfolio and ranking #25.

Has SOFTBANK GROUP CORP. been buying or selling ABCL?

In the latest 13F filing (Q3 2026), SOFTBANK GROUP CORP. reduced its position in ABCL. The position peaked in Q2 2026 at 345.16K shares.

Which other funds hold ABCL?

Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, ADAR1 Capital Management, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.